Fay

Fay

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.faynutrition.com

Last Round

Series B

Mar 26, 2026

Est. Valuation

$500M

Total Funding Raised

$125M

Company Overview

Fay is a digital health company that operates a platform connecting individuals with Registered Dietitians (RDs) for personalized nutrition counseling. The company's primary mission is to make nutrition care more accessible and affordable by ensuring the services are covered by major health insurance providers. For patients, Fay provides a network of over 2,300 dietitians across all 50 states, covering more than 30 specialties. For dietitians, Fay offers an "AI business in a box" platform that handles administrative tasks such as insurance credentialing, billing, and marketing, enabling them to build and grow their private practices. Founded in 2022, the company has raised $75 million in total funding from investors including General Catalyst, Forerunner Ventures, and Goldman Sachs.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Revenue Cycle, Vertical SaaS, Patient Engagement

Business Model

B2B2C

Customer Profile

Payment Processing Fee, Marketplace Commission

AI Layer

Application

Keywords

dietitian marketplacenutrition counselingrevenue cycle managementRCMtelehealth nutritioninsurance billingpractice management softwaredietitian networkvertical SaaSinsurance credentialingdigital health platformchronic condition managementB2B2C marketplaceAI practice managementpatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fay Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fay Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMar 26, 2026
Series BFeb 5, 2025
Series AMay 15, 2024
SeedMay 15, 2023

Key People

Founding team and executive leadership

Sam Faycurry

Co-Founder CEO

Founding Team

Fay Investors

Notable investors and investment history

InvestorRounds
Forerunner VenturesSeries B, Series A
Goldman Sachs Growth EquitySeries B
General CatalystSeries A, Series B, Seed
The Goldman Sachs Group, Inc.Series B
1984 VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2026

    $50M Series B round completed.

  • Mar 1, 2026

    Works with Aetna, BCBS, Cigna, UHC, Humana, Medicare, and Medicaid.

Fay Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fay Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fay's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range463
Year Founded2022
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.